3:50 PM
 | 
Jun 16, 2017
 |  BC Extra  |  Clinical News

Editors reconsidering CRISPR off-target paper's conclusions

Based on reactions to a May 30 letter to Nature Methods that reported an unexpectedly high level of CRISPR-Cas9 off-target activity, the journal noted on June 14 that the conclusions of the paper "are...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >